Pacific Energy Development Corp. (NYSE: PED) engages in the acquisition, exploration, development, and production of oil and natural gas shale plays in the U.S. The company’s principal asset is Denver-Julesberg (D-J) Basin asset comprising approximately 26,990 net acres located in … Continue reading →

Enabling its customers to deliver billions of premium video streams across a matrix of pay-TV, OTT and mobile platforms, SeaChange (NASDAQ: SEAC) empowers service providers, content owners and brand advertisers to entertain audiences, engage consumers and expand business opportunities. As … Continue reading →

NephroGenex, Inc. (NASDAQ: NRX) is an innovator in the development of drugs to treat kidney disease, with a first indication in diabetic nephropathy. NephroGenex has been pioneering the development of PYRIDORIN (pyridoxamine dihydrochloride), a late stage compound to treat diabetic … Continue reading →

VBI Vaccines, Inc. (NASDAQ: VBIV) is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI’s eVLP vaccine platform allows for the design of enveloped (“e”) virus-like particle (“VLP”) vaccines that closely mimic … Continue reading →

OmniComm Systems, Inc. (OTC: OMCM) is a leading strategic software solutions provider to the life sciences industry. OmniComm Systems is dedicated to helping the world’s pharmaceutical; biotechnology; contract research organizations; diagnostic and device firms; and academic medical centers maximize the … Continue reading →

Palatin Technologies, Inc. (NYSE: PTN) is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin’s programs are based on molecules that modulate the activity of the melanocortin … Continue reading →

FluoroPharma Medical, Inc. (OTC MKTS: FPMI) is a biopharmaceutical company engaged in the development of proprietary PET imaging products to evaluate cardiac disease at the cellular and molecular levels. The company’s initial focus is the development of breakthrough PET imaging … Continue reading →

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) is an advanced clinical stage drug development company with a platform technology that is designed to address the treatment of cancer and inflammatory diseases. The company’s CF101 is in Phase II/III trials for the … Continue reading →

uSell.com, Inc. (OTCQB: USEL) is a reCommerce marketplace that helps individuals turn unused items, including personal electronics and cell phones, into cash. The company ensures that customers get the highest payouts with the least amount of hassle by facilitating risk-free … Continue reading →

Towerstream Corporation (NASDAQ: TWER) is a leading 4G and small cell rooftop tower company. The company owns, operates and leases Wi-Fi and rooftop tower locations to cellular phone operators and cable companies, as well as hosting a variety of customers … Continue reading →